☆ 4.3 Editorial Material

Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes trial: A post-hoc analysis

JOURNAL OF DIABETES INVESTIGATION (2021)

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial

Yaling Tang et al.

Summary: This study confirmed the benefits of intensive glycemic therapy and for the first time demonstrated a similar benefit of intensive blood pressure control in preventing CAN in T2D patients. Patients with no history of CVD particularly benefit from intensive glycemic control for CAN prevention.

DIABETES CARE (2021)

Add to Collection
Review Neurosciences

Cardiovascular autonomic neuropathy: A silent killer with long reach

Lynn Ang et al.

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2020)

Add to Collection
Article Endocrinology & Metabolism

Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

Vincenza Spallone et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)

Add to Collection
Article Endocrinology & Metabolism

Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Rodica Pop-Busui et al.

DIABETES CARE (2010)

Add to Collection
Article Endocrinology & Metabolism

Adiponectin concentration in sera from patients with 2 diabetes are negatively association with sympathovagal balance as evaluated by power spectral analysis of heart rate variation

S Wakabayashi et al.

DIABETES CARE (2004)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.